// App-Quantinova.ai

1319 : A novel formulation of CX-5461, a small-molecule inhibitor of rRNA synthesis, and its use for treatment of acute myeloid leukemia models

Researchers

Presenter

  • Ada W.Y. Leung

Principal Investigators

  • Malathi Anantha

  • Kathleen E. Prosser

  • Mohamed Wehbe

  • Charles J. Walsby

  • Marcel B. Bally

Medical Centers

  • British Columbia Cancer Research Centre, Vancouber, British Columbia, Canada.

  • Simon Fraser University, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • INKP-100

  • CX-5461

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • First-In-Human

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved